Analysis of Treatment Effect of α-Interferon and xinganbao in Chronic Hepatitis B
-
摘要: 为了探讨α -干扰素 +心肝宝治疗慢性乙型肝炎的疗效。材料和方法 ,对 1994年 2月~ 1998年 6月我院收治和门诊患者 5 4例 ,随机分成两组。治疗组 2 4例 ,男 18例 ,女 6例 ,平均年龄 37 7岁 ;对照组 30例 ,男 2 2例 ,女 8例 ,平均年龄 31 6岁。各组均检测肝功能 +乙肝系列 ,治疗组用较小剂量的α 2b干扰素 10 0万u ,肌注 ,每日一次 ,同时服心肝宝 6粒 ,一日三次 ,均连用 3个月。对照组用华蟾素每次 4ml,肌注 ,每日一次 ,连用 3个月。结果治疗组抗 -HBcIgM转阴占 5 0 % ,HBeAg转阴占 72 2 % (13/ 18) ,pre s2 转阴占 6 0 % (12 / 2 0 ) ,对照组相应指标为6 0 % ,6 0 % ,47 82 % ,经统计学处理仅HBeAgP <0 0 5。结论 :中小剂量α 2b干扰素 +心肝宝HBeAg转阴率优与对照组。Abstract: To study the treatment effect of α-interferon and xinganbao in chronic hepatitis B.54 cases suffering from chronic hepatitis B were randomly divided into two groups.There were 24 cases in treatment group (man 18 cases, woman 6 cases, average age 37.7 year) , and 30 cases in control group (man 22 cases, woman 8 cases, average age 35.6 year) .The cases in the treatment group were given small dosage of α-2b interferon (100MU, im, qd) and xinganbao (6 capsules, po, tid) .The control was treated with Huachansu (4ml im, gd) for 3 months.The entire course was 3 months.The liver function and HBV-M before and after the treatment were detected result In the treatment, the negative transfer rate in anti-HBcIgM, HBeAg, and Pre-S 2 were 50%, 72.2%and60%, respectively.In the control, they were 60%, 60%, and47.8%, respectively.And only the negative transfer rate of HBeAg is high significantly (P<0.05) .Conclusion The negative transfer rate of HBeAg in the treatment was higher them it in the control.It supports Ha zhong-ying S report in which the negative transfer rate of HBeAg with large dosage α-interferon was 65.9%and zhang xiao-rong S report in which its rate was 66.6%.
-
Key words:
- interferon /
- Xinganbao /
- Treatment chronic Hepatitis B
-
[1]哈忠英 重组干扰素治疗慢性乙型肝炎两年随访 [J] 中华肝脏病杂志 , 1998, 6 (4) ∶2 49 [][2 ]张晓荣 干扰素 αlb治疗慢性乙型肝炎临床疗效分析 [J] 中华肝脏病杂志 , 1998, 6 (2 ) ∶116
本文二维码
计量
- 文章访问数: 3147
- HTML全文浏览量: 14
- PDF下载量: 743
- 被引次数: 0